Hungary's drug regulator has granted initial approval for use of AstraZeneca's and Russia's vaccines against the coronavirus, as reported in This is Money.
Foreign minister Peter Szijjarto was travelling to Moscow for talks about Russia's Sputnik V vaccine later on Thursday.
If he secures a shipment deal with Russia, Hungary would be the first EU member to receive the Sputnik V vaccine, even though the European Medicines Agency (EMA) has yet to green-light the candidate.
Kirill Dmitriev, CEO of the Russian Direct Investment Fund, said on Thursday that Hungary has become the first country in the EU to "realize all the advantages of the Sputnik V vaccine and authorize its use."
He added that "this decision is very important as it demonstrates that the vaccine's safety and efficacy of over 90% are highly regarded by our partners in Hungary."
Meanwhile, the EU regulator has also not yet approved the vaccine co-developed by AstraZeneca and Oxford University, although a decision is expected on January 29.
To read more NewsPoints articles, click here.